Astrana Health (ASTH) Director Mitchell W. Kitayama Sells 8,500 Shares

What Happened
Mitchell W. Kitayama, a director of Astrana Health, disposed of 8,500 shares to the issuer on August 31, 2026 at $37.09 per share, generating $315,265. The Form 4 lists the transaction as a disposition to the issuer (repurchase) rather than an open‑market sale.

Key Details

• Transaction date and price: 2026-08-31 at $37.09 per share. Total proceeds: $315,265.
• Transaction type: Disposition to issuer (company repurchased the shares) — reported as code D.
• Shares owned after transaction: Not specified in this filing.
• Footnotes: F1 — these shares were repurchased by the issuer. F2 — holdings include 4,991 shares of restricted stock that vest the earlier of June 10, 2027 or the issuer's 2027 annual meeting.
• Filing timing: Report filed 2026-09-01 for an 8/31/2026 transaction (filed the next day), which appears to be timely.

Context
A "disposition to issuer" means the company repurchased the shares rather than the insider selling them on the open market. Sales or repurchases by insiders are factual data points; they do not by themselves indicate management sentiment about the business. Purchases tend to carry more weight for bullish signals; this transaction is a routine disposition via company repurchase.